nma.stowe2011: Antiparkinsonian interventions for later Parkinson's disease
In rnmamod: Bayesian Network Meta-Analysis with Missing Participants
nma.stowe2011 R Documentation
Antiparkinsonian interventions for later Parkinson's disease
Description
A dataset of 29 trials comparing three antiparkinsonian
interventions with placebo (a star-shaped network) in patients with later
Parkinson's disease. The analysed continuous outcome is the change from
baseline of patient off-time reduction.
Usage
data(nma.stowe2011)
Format
A data frame with 29 rows of arm-based data and 11 columns (maximum
number of 2 arms).
Details
The interventions have been coded as follows: 1, placebo plus
levodopa (PBO+LD); 2, dopamine agonist plus levodopa (DA+LD);
3, catechol-O-methyl transferase inhibitors plus levodopa (COMBI+LD); and
4, monoamine oxidase type B inhibitors plus levodopa (MAOBI+LD).
Source
Stowe R, Ives N, Clarke CE, et al. Meta-analysis of the comparative efficacy
and safety of adjuvant treatment to levodopa in later Parkinson's disease.
Mov Disord 2011;26(4):587–98. doi: 10.1002/mds.23517
rnmamod documentation built on May 29, 2024, 2:44 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| nma.stowe2011 | R Documentation |
Antiparkinsonian interventions for later Parkinson's disease
Description
A dataset of 29 trials comparing three antiparkinsonian interventions with placebo (a star-shaped network) in patients with later Parkinson's disease. The analysed continuous outcome is the change from baseline of patient off-time reduction.
Usage
data(nma.stowe2011)
Format
A data frame with 29 rows of arm-based data and 11 columns (maximum number of 2 arms).
Details
The interventions have been coded as follows: 1, placebo plus levodopa (PBO+LD); 2, dopamine agonist plus levodopa (DA+LD); 3, catechol-O-methyl transferase inhibitors plus levodopa (COMBI+LD); and 4, monoamine oxidase type B inhibitors plus levodopa (MAOBI+LD).
Source
Stowe R, Ives N, Clarke CE, et al. Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease. Mov Disord 2011;26(4):587–98. doi: 10.1002/mds.23517
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.